Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Cancer Research|October 17, 2008
Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAILSandra Van Schaeybroeck, Donal M Kelly, Joan Kyula, et al.
British Journal of Cancer|March 27, 2024
Identification of unique rectal cancer-specific subtypesBatuhan Kisakol, Anna Matveeva, Manuela Salvucci, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Spatiotemporal dynamics of Mcl-1 abundance and its influence on apoptosis susceptibilityFabian Klötzer, Nadine Pollak, Anna Baatz, et al.
Molecular Cancer Therapeutics|September 3, 2009
Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cellsIrina Proutski, Leanne Stevenson, Wendy L Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecanJohn Boyer, Estelle G McLean, Somaiah Aroori, et al.
Biomaterials|August 31, 2011
Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug deliveryFrancois Fay, Kirsty M McLaughlin, Donna M Small, et al.
Cancer Research|December 15, 2010
Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17Sandra Van Schaeybroeck, Joan N Kyula, Audrey Fenton, et al.
Scientific Reports|December 12, 2023
surviveR: a flexible shiny application for patient survival analysisTamas Sessler, Gerard P Quinn, Mark Wappett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
<i>Fusobacterium nucleatum</i> in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysisChristian Gethings-Behncke, Helen G Coleman, Haydee W T Jordao, et al.
Molecular Pharmaceutics|February 9, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic ToxicityAnas Abed, Michelle K Greene, Alhareth A Alsa'd, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Cancer Research|October 17, 2008
Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAILSandra Van Schaeybroeck, Donal M Kelly, Joan Kyula, et al.
British Journal of Cancer|March 27, 2024
Identification of unique rectal cancer-specific subtypesBatuhan Kisakol, Anna Matveeva, Manuela Salvucci, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Spatiotemporal dynamics of Mcl-1 abundance and its influence on apoptosis susceptibilityFabian Klötzer, Nadine Pollak, Anna Baatz, et al.
Molecular Cancer Therapeutics|September 3, 2009
Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cellsIrina Proutski, Leanne Stevenson, Wendy L Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecanJohn Boyer, Estelle G McLean, Somaiah Aroori, et al.
Biomaterials|August 31, 2011
Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug deliveryFrancois Fay, Kirsty M McLaughlin, Donna M Small, et al.
Cancer Research|December 15, 2010
Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17Sandra Van Schaeybroeck, Joan N Kyula, Audrey Fenton, et al.
Scientific Reports|December 12, 2023
surviveR: a flexible shiny application for patient survival analysisTamas Sessler, Gerard P Quinn, Mark Wappett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
<i>Fusobacterium nucleatum</i> in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysisChristian Gethings-Behncke, Helen G Coleman, Haydee W T Jordao, et al.
Molecular Pharmaceutics|February 9, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic ToxicityAnas Abed, Michelle K Greene, Alhareth A Alsa'd, et al.
Pageof 12